about
Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & ImmunologyRecombinant allergens: the present and the futureSublingual immunotherapy (SLIT)--indications, mechanism, and efficacy: Position paper prepared by the Section of Immunotherapy, Polish Society of AllergyEAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.First European data from the network of severe allergic reactions (NORA).Histamine receptor expression on peripheral blood lymphocytes is influenced by specific and nonspecific activation.T-cell subset regulation in atopy.Immune regulation by histamine.Histamine in allergic inflammation and immune modulation.Histamine in chronic allergic responses.Are regulatory T cells the target of venom immunotherapy?The role of histamine in regulation of immune responses.Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union.Histamine receptors in immune regulation and allergen-specific immunotherapy.Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.Research needs in allergy: an EAACI position paper, in collaboration with EFA.Highlights in cellular and molecular mechanisms of allergic diseases. XXVth Congress of the European Academy of Allergology and Clinical Immunology in Vienna.Regulatory effects of histamine and histamine receptor expression in human allergic immune responses.T-cell regulatory mechanisms in specific immunotherapy.Histamine, histamine receptors and their role in immune pathology.Immunological mechanisms of allergen-specific immunotherapy.Untangling asthma phenotypes and endotypes.Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report.Human T regulatory cells: on the way to cognition.Allergy management in primary care across European countries -- actual status.Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report.Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development.Histamine and gut mucosal immune regulation.Novel immunotherapy vaccine development.A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease.Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews.Exposure to nonmicrobial N-glycolylneuraminic acid protects farmers' children against airway inflammation and colitis.Validation of the Global Allergy and Asthma European Network (GA2LEN) chamber for trials in allergy: Innovation of a mobile allergen exposure chamber.Improving allergy management in the primary care network--a holistic approach.Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA2LEN studyClinical results from vaccination with recombinant grass pollen allergens.Erratum to: Allergen immunotherapy for allergic asthma: protocol for a systematic review.Allergen-Specific Immunotherapy in Asthma.T-cell regulation during viral and nonviral asthma exacerbations.Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression.
P50
Q26751386-EB8FF63D-0148-4C0F-A519-1BAAF1D87369Q26996701-33D73EB1-EF84-4076-84D8-6903C2176836Q28077308-6B4728CD-B6ED-487E-A0D1-B09B0786521DQ30394524-DC4A6A26-A285-4F4A-A6BA-32E75B5BB897Q30834791-7FFF8276-1DB0-499E-8821-6EF29F1C6046Q30870243-DACA9700-0E03-4766-8F44-3AADB4A2E7F3Q34617024-39B5E269-AD89-41CB-8411-1D605D17B5E6Q34987280-DA3CBA05-F89C-4F1A-94D8-3726669F4408Q36098788-84A74703-4944-4DB1-B6FB-D81454F9D4BAQ36112183-A03CA504-C1D1-4871-8E30-20B637790994Q36178094-1D98F10F-5FA0-421A-9605-B121E3F7CC58Q36342212-0F314364-2076-4D62-9603-E641ED4114C1Q36417095-8E63C5EC-61CD-4866-B0B2-45554B9C080FQ36479007-8E786682-E470-437E-BAED-AF8C97779EAFQ36515366-17EC6A21-6F25-49D3-B186-8336EEA3AAD4Q36517533-E4FD3FB2-B566-45C1-9763-D70145EF9877Q36620084-C761734C-AC6C-4154-970B-C5FB879E1F82Q37273130-87F80C97-6E7C-4443-9DA7-D3A0690A9718Q37273160-BFFCFB8E-9377-4B21-80D0-F4C7AC28F079Q37677823-E2BF1BBD-30FA-43FC-9E19-4F350E5507CDQ37861875-F21AFD83-6D82-4B1B-AD6F-7B1D88BED9D4Q38010795-D432CB65-66A8-403D-80B6-A66872A70666Q38090066-6D290562-BC2B-4F21-9F0B-6958A5228D9AQ38093785-E8EED879-E217-4553-9AAF-946093F171D1Q38111850-33DBBF9C-DB00-46A7-B965-3AC692B27F57Q38134763-68E1A5B2-70DD-4457-96F8-3CE9D6D5C85EQ38155063-074D5154-89ED-45D9-89B8-EDF0267495DBQ38167039-274D7610-D49C-4AEE-AFD1-4E0DDC91C235Q38258988-9A73E94A-9938-47DC-9C54-472E59AE83D6Q38373177-98DCDE71-8B71-4E81-B628-850469670974Q38641971-42FA4A36-8462-41A4-B284-41E44277BF8CQ39011616-8F60F3CA-3A99-4B26-A551-861ACAE139A7Q39327535-2E40B8D0-13CE-4799-AEE2-5100683DB3D6Q39334666-C6645F33-DFAD-459D-B0FE-5373997D0AB3Q41712705-EBA1A6FF-D692-47D5-B3D8-97876AA03792Q42121533-EB6DE157-052E-43EF-9291-E36E65E71D96Q42360180-F6D6AF7F-366B-451D-812E-95B1F4C72E25Q42587580-8AF83E4E-1C56-41D8-A85A-3BB1B0F60A95Q43489644-F4C4C4BE-D9F2-4F8E-9C0F-B3A9402775A0Q43578508-FE8A129B-51A3-4083-BE42-5F2FC080FABD
P50
description
Polish allergist
@en
dokter
@id
polski lekarz alergolog
@pl
name
Marek Jutel
@ast
Marek Jutel
@ca
Marek Jutel
@cs
Marek Jutel
@de
Marek Jutel
@en
Marek Jutel
@es
Marek Jutel
@fr
Marek Jutel
@ga
Marek Jutel
@gl
Marek Jutel
@hr
type
label
Marek Jutel
@ast
Marek Jutel
@ca
Marek Jutel
@cs
Marek Jutel
@de
Marek Jutel
@en
Marek Jutel
@es
Marek Jutel
@fr
Marek Jutel
@ga
Marek Jutel
@gl
Marek Jutel
@hr
altLabel
Marek Michał Jutel
@pl
prefLabel
Marek Jutel
@ast
Marek Jutel
@ca
Marek Jutel
@cs
Marek Jutel
@de
Marek Jutel
@en
Marek Jutel
@es
Marek Jutel
@fr
Marek Jutel
@ga
Marek Jutel
@gl
Marek Jutel
@hr
P214
P101
P106
P1412
P1559
Marek Jutel
@pl
P21
P214
P27
P31
P3124
P569
1964-01-01T00:00:00Z
P7859
viaf-311135999